Esra KAZAK, Cüneyt ÖZAKIN, Emel GÜRCÜOĞLU, Hicran GÜLER, Saliha ÖZBEY BAKIR, Ayşe Melda SINIRTAŞ

A study on molecular characterization of macrolide resistance mechanism among isolates of Streptococcus pneumoniae from the southern Marmara region of Turkey, as well as resistance to macrolides and penicillin in these isolates

To determine the distribution of macrolide resistance genes as well as resistance rates in isolated Streptococcus pneumoniae strains from the southern Marmara region of Turkey. Materials and methods: Antimicrobial resistance rates and MIC values were determined by the E-test method in 300 Streptococcus pneumoniae isolates that were isolated from clinical samples. Resistance genes were determined by the polymerase chain reaction (PCR) method in erythromycin-resistant strains. Results: It was found that 11.4% of Streptococcus pneumoniae isolates were resistant to macrolides. The penicillin MIC value was >=0.12 µg/mL in 23% of the strains and 2 µg/mL in 2% of the strains. The erm(B) genotype was observed in 58.8% of all macrolide-resistant strains, 38.2% were of the mef(A) genotype, and 3% were a combination of both genotypes. Conclusion: Based on the data from this study, it was concluded that the local resistance to antibiotics is not as high as that observed in other countries, and the erm(B) genotype was dominant in macrolide-resistant strains. Therefore, it is suggested that macrolide-group antibiotics still be included in treatment protocols.

Anahtar Kelimeler:

Key words: Mef(A), erm(B), PCR, S. pneumoniae

A study on molecular characterization of macrolide resistance mechanism among isolates of Streptococcus pneumoniae from the southern Marmara region of Turkey, as well as resistance to macrolides and penicillin in these isolates

Keywords:

Key words: Mef(A), erm(B), PCR, S. pneumoniae,

PDF

___

Felmingham D, Reinert RR, Hirakata Y, Rodloff A. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study and comparative in-vitro activity of the ketolide, telithromycin. J Antimicrob Chemoth 2002; 50 (Suppl S1): 25- 37.
Gür D, Özalp M, Sümerkan B, Kaygusuz A, Töreci K, Köksal İ et al. Prevalence of antimicrobial resistance in Haemophilus infl uenzae, Streptococcus pneumoniae, Moraxella catarrhalis and Streptococcus pyogenes: results of a multicentre study in Turkey. Int J Antimicrob Ag 2002; 19: 207-11.
Özalp M, Kanra G, Gür D. Distribution of serotypes and antimicrobial resistance of Streptococcus pneumoniae in a children’s hospital in Turkey. Th e Turkish Journal of Pediatrics 2004; 46: 329-32.
Ruoff KL, Whiley RA, Beighton D. Streptococcus. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, editors. Manual of clinical microbiology. 8th ed. Washington (DC): ASM Press; 2003. p.405-17.
Jorgensen JH, Ferraro MJ, McElmeel ML, Spargo J, Swenson JM, Tenover FC. Detection of penicillin and extended- spectrum cephalosporin resistance among S. pneumoniae clinical isolates by use of the E test. J Clin Microbiol 1994; 32: 159-63.
Farrell DJ, Morrissey I, Bakker S, Felmingham D. Detection of macrolide resistance mechanisms in Streptococcus pneumoniae and Streptococcus pyogenes using a multiplex rapid cycle PCR with microwell-format probe hybridization. J Antimicrob Chemoth 2001; 48: 541-44.
Sutcliff e J, Grebe T, Tait-Kamradt A, Wondrack L. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 1996; 11: 2562-66.
Sutcliff e J, Tait-Kamradt A, Clancy J, Cronan M, Dib-Hajj F, Wondrack L et al. mefE is necessary for the erythromycin- resistant M phenotype in Streptococcus pneumoniae. Antimicrob Agents Chemother 1997; 41: 2251-55.
Tenover FC, Rasheed JK. Detection of antimicrobial resistance genes and mutations associated with antimicrobial resistance in microorganisms. In: Persing DH, Tenover FC, Versalovic J, Tang Y, Unger ER, Relman DA et al., editors. Molecular microbiology: diagnostic principles and practice. Washington (DC): ASM Press; 2004. p.391-406.
Doern GV, Brown SD. Antimicrobial susceptibility among community-acquired respiratory tract pathogens in the USA: data from PROTEKT US 2000-01. J Infection 2004; 48: 56-65.
Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN, Alexander Project Group. Th e Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemoth 2003; 52: 229-46.
Sener B, Köseoglu O, Gür D, Bryskier A. Mechanisms of macrolide resistance in clinical pneumococcal isolates in a university hospital, Ankara, Turkey. J Chemother 2005; 17: 31- 5.
Gür D, Mülazımoğlu L, Unal S, e-BASKETT-II Calışma Grubu In vitro susceptibility of respiratory isolates of Streptococcus pneumoniae and Streptococcus pyogenes to telithromycin and 11 other antimicrobial agents: Turkish results of e-BASKETT- II surveillance study. Mikrobiyol Bul 2007; 41: 1-9 (in Turkish).
Gulay Z, Ozbek OA, Bicmen M, Gur D. Macrolide resistance determinants in erythromycin-resistant Streptococcus pneumoniae in Turkey. Jpn J Infect Dis. 2008; 61: 490-3.